Hallervorden-Spatz disease is a movement disorder that is passed down through families (inherited).
Pantothenate kinase-associated neurodegeneration
Hallervorden-Spatz disease usually begins in childhood.
Most cases of Hallervorden-Spatz disease are due to a defect in a gene that makes a protein called pantothenate kinase 2. Patients with this genetic defect have a buildup of iron in parts of the brain.
The doctor will perform a physical exam and ask questions about the patient's medical history. It is important to get a complete medical and family history, since the condition can run in families.
A neurological examination will show:
Genetic tests can look for the defective gene that causes the disease. However, this test is not yet widely available. It is only found at certain research laboratories.
Tests such as MRI can help rule out other movement disorders and diseases.
The goal of treatment is to control the symptoms. There is no specific treatment for Hallervorden-Spatz disease.
Hallervorden-Spatz gets worse and damages the nerves over time. It leads to a lack of movement and often death by early adulthood.
Medication used to treat symptoms can cause complications. Being unable to move from the disease can lead to:
Call your health care provider if your child develops:
Genetic counseling is appropriate in families affected by this illness. There is no known way to prevent it.
Lang A. Other movement disorders. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007:chap 434.